Great presentation of our latest #STAMPEDEtrial M1 RT data by Chris Parker Simultaneous publication in The Lancet Here’s the link dx.doi.org/10.1016/S0140-… #ESMO18

Great to see #radiotherapy headlining at the medical oncology conference #ESMO18. Improved survival by radiotherapy to the prostate in low volume M1 CSPC. #STAMPEDEtrial data presented by Chris Parker

18% had ADT + Doc as their SOC. adding RT to this had a similar HR to the effect of adding RT to ADT monotherapy (slightly bigger in fact). ADT/Doc/RT will be our SOC for this group in future in chemo fit pts

Merck’s KEYTRUDA® (pembrolizumab) in Combination with Pfizer’s Inlyta® (axitinib) Significantly Improved Overall Survival (OS) and Progression-free Survival (PFS) as First-Line Therapy for Advanced or Metastatic Renal Cell Carcinoma | Business Wire businesswire.com/news/home/2018…

Bent lanserer #ekspertpanelet @ Haukeland universitetssjukehus instagram.com/p/BpmM-3iHe11/…

Bent lanserer #ekspertpanelet instagram.com/p/BpmNgwQHXKl/…

Den mest udiskutable fredsprisen på lenge deles ut, men avisene rydder forsidene for Farmen-Kjetil. Det får være måte på forsimpling av offentligheten, VG og Dagbladet. Dette er flaut.

MASTERSKONK FREDAG: Best siste 9 hull mellom Tiger Woods & Rory McIlroy. Retweet for Tiger, ´like´for Rory. Lykke til! Per Haugsrud 👍

MASTERSKONK LØRDAG: Best siste 9 hull av Tiger Woods & Ian Poulter. Retweet for Tiger, ´like´for Poulter. Poulter-sko i premie! Per Haugsrud #ESNgolf

Getting ready for day 1 #ASCO19

Out now! Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019 published on European Urology 👉 europeanurology.com/article/S0302-… #apccc19 #apccc21 #prostatecancer @Els_Urology UroToday.com

SØNDAGSKONK #1: Best siste 6 hull av Rory McIlroy & Jon Rahm Rodriguez. Retweet for McIlroy, ´like´for Rahm. #ESNgolf golfshopen.no

Overbevist at det å godkjenne COVID-19 vaksinene nå er riktig og glad for at utviklingen har gått så fort! Støtter også veldig å flytte helsepersonell frem i prioriteringskøen og skal utvilsomt være en av de første som vaksineres selv når det er min tur! dagensmedisin.no/artikler/2020/…

Lenvatinib + pembro is at least as active as other VEGF/IO combos. RR of 70% + PFS of 24 mnths (yes 24) are eye catching. OS of 0.66 in line with others. Low LFT AEs is important. Lenvatinib + evero has PFS but not OS signal. It’s role requires definition. ?post cabo/nivo #GU21

#APCCC21

Verdens beste kreftbehandling on tidsskriftet.no tidsskriftet.no/2021/09/leder/… #tidsskriftet via Tidsskriftet

Four hours with Tom and Brian on my ears and this view in front of my eyes! Really exhausting 😎☀️😁 Tom Powles Brian Rini, MD Uromigos

#APCCC24 is on the horizon, launching on April 25th! As a consensus conference, it’s the epicentre for bridging clinical gaps in advanced #prostatecancer care. The world’s experts gather to tackle crucial topics and highlight the evolving dynamics of #PCa treatment. 🌍 With an

HERE IN #APCCC24 🇨🇭 IT'S ALL ABOUT THAT PSMA Advanced Prostate Cancer Consensus Conference silke gillessen aurelius omlin Neeraj Agarwal, MD, FASCO Ravindran Kanesvaran Simon C Eleni Efstathiou Dra. María Natalia Gandur Quiroga A/Prof. Shahneen Sandhu Christopher Sweeney, MBBS Daniel E Spratt Howard Soule neal shore @RobertReiterMD Dana Rathkopf Colin Pritchard

Our data on prediction of benefit from Radium-223 in #mCRPC The Patrick G Johnston Centre for Cancer Research #ProEx published today nature.com/articles/s4141…